J. P. Rissing

1.4k total citations
50 papers, 1.1k citations indexed

About

J. P. Rissing is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, J. P. Rissing has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in J. P. Rissing's work include Antimicrobial Resistance in Staphylococcus (12 papers), Orthopedic Infections and Treatments (11 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). J. P. Rissing is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (12 papers), Orthopedic Infections and Treatments (11 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). J. P. Rissing collaborates with scholars based in United States and Ireland. J. P. Rissing's co-authors include Thomas B. Buxton, R K Shockley, G. F. Brooks, Donald R. Nelson, James W. Smith, William L. Moore, Robert S. Weinstein, Terry Joe Sprinkle, John F. Fisher and W. M. Jay and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

J. P. Rissing

50 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Rissing United States 19 439 286 271 158 156 50 1.1k
Starkey D. Davis United States 20 183 0.4× 171 0.6× 230 0.8× 107 0.7× 127 0.8× 43 1.2k
Michael C. Bach United States 16 176 0.4× 246 0.9× 485 1.8× 97 0.6× 48 0.3× 32 870
J. Rollof Sweden 17 267 0.6× 176 0.6× 203 0.7× 153 1.0× 280 1.8× 39 1.3k
Clara Larcher Austria 26 141 0.3× 445 1.6× 693 2.6× 109 0.7× 203 1.3× 79 1.8k
R. van Furth Netherlands 21 104 0.2× 308 1.1× 356 1.3× 112 0.7× 227 1.5× 42 1.4k
Helmut Schöfer Germany 23 194 0.4× 320 1.1× 668 2.5× 174 1.1× 99 0.6× 88 1.8k
Glenn R. Hodges United States 16 96 0.2× 175 0.6× 311 1.1× 82 0.5× 71 0.5× 44 807
Natalie C. Klein United States 14 154 0.4× 326 1.1× 394 1.5× 73 0.5× 98 0.6× 41 943
Juan C. Sarria United States 15 153 0.3× 289 1.0× 228 0.8× 51 0.3× 75 0.5× 53 667
Beryl Jameson United Kingdom 18 100 0.2× 368 1.3× 538 2.0× 271 1.7× 85 0.5× 35 1.7k

Countries citing papers authored by J. P. Rissing

Since Specialization
Citations

This map shows the geographic impact of J. P. Rissing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Rissing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Rissing more than expected).

Fields of papers citing papers by J. P. Rissing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Rissing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Rissing. The network helps show where J. P. Rissing may publish in the future.

Co-authorship network of co-authors of J. P. Rissing

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Rissing. A scholar is included among the top collaborators of J. P. Rissing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Rissing. J. P. Rissing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, William, Cheryl Newman, J. P. Rissing, et al.. (2001). Identification of Non‐B Human Immunodeficiency Virus Type 1 Subtypes in Rural Georgia. The Journal of Infectious Diseases. 183(1). 138–142. 17 indexed citations
2.
Rissing, J. P.. (1997). Antimicrobial Therapy for Chronic Osteomyelitis in Adults: Role of the Quinolones. Clinical Infectious Diseases. 25(6). 1327–1333. 76 indexed citations
3.
Rissing, J. P., et al.. (1995). Group B Streptococcal Vertebral Osteomyelitis With Bacteremia. Southern Medical Journal. 88(3). 350–351. 11 indexed citations
4.
Rissing, J. P., et al.. (1994). The effect of growth temperature on Staphylococcus aureus binding to type I collagen. Microbial Pathogenesis. 17(4). 239–251. 8 indexed citations
5.
Nelson, Donald R., et al.. (1990). The promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis. Journal of Thoracic and Cardiovascular Surgery. 99(6). 977–980. 81 indexed citations
6.
Rissing, J. P.. (1990). Animal models of osteomyelitis. Knowledge, hypothesis, and speculation.. PubMed. 4(3). 377–90. 40 indexed citations
7.
Nelson, Donald R., et al.. (1990). An antibiotic resistant experimental model of Pseudomonas osteomyelitis. Infection. 18(4). 246–248. 15 indexed citations
8.
Buxton, Thomas B., et al.. (1989). Treatment of chronic experimentalStaphylococcus aureus osteomyelitis with LY146032 and vancomycin. European Journal of Clinical Microbiology & Infectious Diseases. 8(6). 562–563. 21 indexed citations
9.
Buxton, Thomas B., et al.. (1986). Quantitation of phospholipase A2 and phospholipase C activity using alkaline phosphatase impregnated liposomes. Microchemical Journal. 34(3). 349–354. 1 indexed citations
10.
Rissing, J. P., et al.. (1985). Multistrain Comparison of Three Antimicrobial Prophylaxis Regimens in Experimental Postoperative Pseudomonas Endophthalmitis. American Journal of Ophthalmology. 100(3). 404–407. 11 indexed citations
11.
Rissing, J. P., et al.. (1985). Arachidonic acid facilitates experimental chronic osteomyelitis in rats. Infection and Immunity. 49(1). 141–144. 34 indexed citations
12.
Shockley, R K, et al.. (1985). Effect of inoculum size on the induction of endophthalmitis in aphakic rabbit eyes. Acta Ophthalmologica. 63(1). 35–38. 45 indexed citations
13.
Rissing, J. P., et al.. (1984). Postoperative Wound Infections Following Cardiac Surgery: Significance of Contaminated Cases Performed in the Preceding 48 Hours. Infection Control. 5(8). 371–377. 6 indexed citations
14.
Harris, Richard W., et al.. (1984). Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraperitoneal abscess model. Journal of Antimicrobial Chemotherapy. 14(5). 499–508. 3 indexed citations
15.
Rissing, J. P., et al.. (1984). Ceftriaxone therapy for serious bacterial infections. 36(3). 574–581. 3 indexed citations
16.
Sprinkle, Terry Joe, Harold J. Sheedlo, Thomas B. Buxton, & J. P. Rissing. (1983). Immunochemical Identification of 2′, 3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in Central and Peripheral Nervous System Myelin, the Wolfgram Protein Fraction, and Bovine Oligodendrocytes. Journal of Neurochemistry. 41(6). 1664–1671. 33 indexed citations
17.
Je, Doran & J. P. Rissing. (1983). Influence of clindamycin on fibronectin-staphylococcal interactions. Journal of Antimicrobial Chemotherapy. 12(suppl C). 75–83. 15 indexed citations
18.
Fisher, John F., Francis J. Tedesco, David H. Johnson, et al.. (1982). Discontinuous Counterimmunoelectrophoresis in the Diagnosis of Antibiotic-Associated Colitis. Journal of Clinical Gastroenterology. 4(3). 253–256. 1 indexed citations
19.
Rissing, J. P., Cheryl Newman, & William L. Moore. (1978). Artifactual Depression of Serum Glutamic Oxaloacetic Transaminase by Metronidazole. Antimicrobial Agents and Chemotherapy. 14(4). 636–638. 13 indexed citations
20.
Brooks, G. F., et al.. (1974). EIKENELLA CORRODENS, A RECENTLY RECOGNIZED PATHOGEN. Medicine. 53(5). 325–342. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026